Abstract:Both Parkinson's disease (PD) and multiple system atrophy (MSA) are α-synucleinopathies [ [1] Barker R.A. Williams-Gray C.H. Review: the spectrum of clinical features seen with alpha synuclein pathology. Neuropathol. Appl. Neurobiol. 2016; 42: 6-19 Crossref PubMed Scopus (59) Google Scholar ] that share clinical characteristics and genetic risk factors [ 2 Puschmann A. Bhidayasiri R. Weiner W.J. Synucleinopathies from bench to bedside. Parkinsonism Relat. Disord. 2012; 18: S24-S27 Abstract Full Text PDF PubMed Google Scholar , 3 Kiely A.P. Asi Y.T. Kara E. Limousin P. Ling H. Lewis P. et al. Alpha-synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?. Acta Neuropathol. 2013; 125: 753-769 Crossref PubMed Scopus (299) Google Scholar ]. Therefore we wanted to investigate whether TMEM230 mutations recently linked to risk of PD may also influence risk of MSA. The mutation c.422G > T (p.Arg141Leu) has been associated with risk of autosomal dominant PD in a Caucasian family [ [4] Deng H.X. Shi Y. Yang Y. Ahmeti K.B. Miller N. Huang C. et al. Identification of TMEM230 mutations in familial Parkinson's disease. Nat. Genet. 2016; 48: 733-739 Crossref PubMed Scopus (128) Google Scholar ], and a study of 433 Caucasian cases of familial PD and 399 Caucasian cases of sporadic PD has linked the mutation c.551A > G (p.*184Trpext*5) with familial disease and the mutation c.275A > G (p.Tyr92Cys) with sporadic disease [ [6] Goldstein D.S. Sullivan P. Holmes C. Miller G.W. Sharabi Y. Kopin I.J. A vesicular sequestration to oxidative deamination shift in myocardial sympathetic nerves in Parkinson's disease. J. Neurochem. 2014; 131: 219-228 Crossref PubMed Scopus (27) Google Scholar ]. A fourth mutation, which was a stop codon (c.550_552del TAGinsCCCGGG, p.*184Pro Glyext*5), has been linked to risk of familial PD in a study of seven Han Chinese families [ [4] Deng H.X. Shi Y. Yang Y. Ahmeti K.B. Miller N. Huang C. et al. Identification of TMEM230 mutations in familial Parkinson's disease. Nat. Genet. 2016; 48: 733-739 Crossref PubMed Scopus (128) Google Scholar ]. Consistent with these genetic associations, PD has been linked to impaired vesicle trafficking and recycling, and the TMEM230 protein participates in exocytosis, endocytosis and recycling of synaptic vesicles in neurons [ [4] Deng H.X. Shi Y. Yang Y. Ahmeti K.B. Miller N. Huang C. et al. Identification of TMEM230 mutations in familial Parkinson's disease. Nat. Genet. 2016; 48: 733-739 Crossref PubMed Scopus (128) Google Scholar ]. Post-mortem and in vivo studies of PD have identified substantially decreased vesicular sequestration of cytoplasmic catecholamines in residual terminals in putamen and heart, leading to accumulation of the toxic dopamine metabolite 3,4-dihydroxyphenylacetaldehyde (DOPAL) [ 5 Goldstein D.S. Sullivan P. Holmes C. Miller G.W. Alter S. Strong R. et al. Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease. J. Neurochem. 2013; 126: 591-603 Crossref PubMed Scopus (136) Google Scholar , 6 Goldstein D.S. Sullivan P. Holmes C. Miller G.W. Sharabi Y. Kopin I.J. A vesicular sequestration to oxidative deamination shift in myocardial sympathetic nerves in Parkinson's disease. J. Neurochem. 2014; 131: 219-228 Crossref PubMed Scopus (27) Google Scholar ].

The genetic basis of multiple system atrophy

Genetic profiles of multiple system atrophy revealed by exome sequencing, long‐read sequencing and spinocerebellar ataxia repeat expansion analysis

Genome sequence analyses identify novel risk loci for multiple system atrophy

New advances in multiple system atrophy

Multiple System Atrophy: Pathology, Pathogenesis, and Path Forward

Multiple System Atrophy: Recent Developments and Future Perspectives

Genes associated with multiple system atrophy

Clinical and Pathological Characteristics of Multiple System Atrophy

SNP Rs11931074 of Thesncagene May Not Be Associated with Multiple System Atrophy in Chinese Population

Blood–brain barrier dysfunction in multiple system atrophy: A human postmortem study

Is Multiple System Atrophy a Prion-like Disorder?

Transcriptomic insights into multiple system atrophy from a PLP-α-synuclein transgenic mouse model

Dilemma of multiple system atrophy and spinocerebellar ataxias

Sequence TMEM230 Gene in Patients with Multiple System Atrophy in a Southwest Chinese Population: A Pilot Study

In Vivo Cerebral Metabolic and Dopaminergic Characteristics in Multiple System Atrophy with Orthostatic Hypotension.

Multiple system atrophy: an update and emerging directions of biomarkers and clinical trials

Data-Driven Subtypes of Multiple System Atrophy and Their Implications for Prognosis

Understanding the potential causes of gastrointestinal dysfunctions in multiple system atrophy

Multiple system atrophy: Diagnostic challenges and a proposed diagnostic algorithm

Non-pharmacological and drug treatment of autonomic dysfunction in multiple system atrophy: current status and future directions

Candidate biomarkers of multiple system atrophy in cerebrospinal fluid